Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ENTYVIO
- A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
- An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
- Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Defining Predictors of RT Response to Vedolizumab in IBD
- Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
- A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)
- Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
- Synergistic Effect of Vedolizumab and Pentoxifylline
- Vedolizumab Induction May Prevent Celiac Enteritis
- Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease
- Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
- Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
- Vedolizumab Post Op Study
- A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
- Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease
- Triple Combination Therapy in High Risk Crohn's Disease (CD)
- Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
- Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma
- OTIS Vedolizumab Pregnancy Exposure Registry
- Entyvio (Vedolizumab) Long Term Safety Study
- A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study
- An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
- Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease
- Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
- Corticosteroids With Vedolizumab in Crohn's Disease
- Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
- Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
- Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
- Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
- Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
- Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Clinical trials list
click for details